$ACHC
Acadia Healthcare Company, Inc.

2018 Q4 Form 10-Q Financial Statement

#000156459018027458 Filed on November 06, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $743.5M $760.9M $716.7M
YoY Change 2.63% 6.17% -2.44%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin -$287.4M $526.8M $486.3M
YoY Change -158.32% 8.33% -3.93%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $39.40M $39.70M $36.50M
YoY Change 4.51% 8.77% 0.27%
% of Gross Profit
Operating Expenses -$348.7M $705.9M $655.3M
YoY Change -156.87% 7.73% -22.95%
Operating Profit $148.9M $152.3M
YoY Change -2.19% -2.3%
Interest Expense -$46.80M -$46.70M -$44.50M
YoY Change 3.54% 4.94% -8.81%
% of Operating Profit -31.36% -29.23%
Other Income/Expense, Net
YoY Change
Pretax Income -$341.3M $55.04M $61.46M
YoY Change -662.43% -10.45% -153.07%
Income Tax -$16.90M $8.757M $15.97M
% Of Pretax Income 15.91% 25.98%
Net Earnings -$331.6M $46.23M $45.62M
YoY Change -576.29% 1.35% -138.72%
Net Earnings / Revenue -44.6% 6.08% 6.36%
Basic Earnings Per Share -$3.80 $0.53 $0.52
Diluted Earnings Per Share -$3.80 $0.53 $0.52
COMMON SHARES
Basic Shares Outstanding 88.26M 87.34M 87.02M shares
Diluted Shares Outstanding 87.54M 87.17M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.50M $48.90M $75.70M
YoY Change -24.96% -35.4% 172.3%
Cash & Equivalents $50.51M $48.93M $75.66M
Short-Term Investments
Other Short-Term Assets $81.82M $96.15M $92.41M
YoY Change -23.77% 4.05% 5.45%
Inventory $5.055M $5.021M $4.698M
Prepaid Expenses $30.80M $35.68M $28.87M
Receivables $318.1M $345.7M $295.8M
Other Receivables $19.21M $30.20M $30.91M
Total Short-Term Assets $450.4M $490.7M $463.8M
YoY Change -4.48% 5.8% 18.04%
LONG-TERM ASSETS
Property, Plant & Equipment $3.108B $3.127B $2.966B
YoY Change 1.96% 5.41% 6.44%
Goodwill $2.045B $2.730B $2.730B
YoY Change -25.67% -0.02% 1.05%
Intangibles $88.99M $91.26M $86.95M
YoY Change 1.88% 4.95% 3.04%
Long-Term Investments
YoY Change
Other Assets $64.93M $54.30M $65.37M
YoY Change 30.98% -16.94% 60.16%
Total Long-Term Assets $5.722B $6.039B $5.879B
YoY Change -3.88% 2.72% -2.99%
TOTAL ASSETS
Total Short-Term Assets $450.4M $490.7M $463.8M
Total Long-Term Assets $5.722B $6.039B $5.879B
Total Assets $6.173B $6.530B $6.343B
YoY Change -3.92% 2.95% -1.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $117.7M $133.9M $95.11M
YoY Change 15.09% 40.81% 2.46%
Accrued Expenses $224.4M $175.7M $39.61M
YoY Change 502.13% 343.57% -7.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $34.11M $33.26M $34.81M
YoY Change -2.06% -4.43% -55.15%
Total Short-Term Liabilities $416.4M $390.7M $341.2M
YoY Change 10.33% 14.52% -10.27%
LONG-TERM LIABILITIES
Long-Term Debt $3.159B $3.182B $3.234B
YoY Change -1.43% -1.61% -9.76%
Other Long-Term Liabilities $154.3M $165.7M $179.3M
YoY Change -7.31% -7.62% 21.87%
Total Long-Term Liabilities $3.314B $3.348B $3.413B
YoY Change -1.72% -1.93% -8.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $416.4M $390.7M $341.2M
Total Long-Term Liabilities $3.314B $3.348B $3.413B
Total Liabilities $3.810B $3.821B $3.836B
YoY Change -0.49% -0.41% -8.5%
SHAREHOLDERS EQUITY
Retained Earnings $252.8M $584.5M $358.9M
YoY Change -41.01% 62.83% 101.29%
Common Stock $2.543B $2.536B $2.514B
YoY Change 0.97% 0.89% 0.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.333B $2.680B $2.488B
YoY Change
Total Liabilities & Shareholders Equity $6.173B $6.530B $6.343B
YoY Change -3.92% 2.95% -1.71%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$331.6M $46.23M $45.62M
YoY Change -576.29% 1.35% -138.72%
Depreciation, Depletion And Amortization $39.40M $39.70M $36.50M
YoY Change 4.51% 8.77% 0.27%
Cash From Operating Activities $127.9M $68.90M $83.80M
YoY Change -0.23% -17.78% 9.11%
INVESTING ACTIVITIES
Capital Expenditures -$100.4M -$89.00M -$86.70M
YoY Change 13.96% 2.65% 6.12%
Acquisitions
YoY Change
Other Investing Activities $2.000M $200.0K -$200.0K
YoY Change -113.16% -200.0%
Cash From Investing Activities -$98.50M -$88.80M -$86.90M
YoY Change -4.65% 2.19% 6.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.60M -10.10M -4.300M
YoY Change -18.4% 134.88% -238.71%
NET CHANGE
Cash From Operating Activities 127.9M 68.90M 83.80M
Cash From Investing Activities -98.50M -88.80M -86.90M
Cash From Financing Activities -26.60M -10.10M -4.300M
Net Change In Cash 2.800M -30.00M -7.400M
YoY Change -136.36% 305.41% 289.47%
FREE CASH FLOW
Cash From Operating Activities $127.9M $68.90M $83.80M
Capital Expenditures -$100.4M -$89.00M -$86.70M
Free Cash Flow $228.3M $157.9M $170.5M
YoY Change 5.55% -7.39% 7.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
249161000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
164390000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-130777000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-810000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
126000
CY2017Q4 us-gaap Assets
Assets
6424502000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49572000
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88256115
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48928000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67290000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
345659000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296925000
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
96146000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107335000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
490733000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
471550000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3126642000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3048130000
CY2018Q3 us-gaap Goodwill
Goodwill
2729941000
CY2017Q4 us-gaap Goodwill
Goodwill
2751174000
CY2018Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
91259000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
87348000
CY2018Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3630000
CY2017Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3731000
CY2018Q3 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
33084000
CY2017Q4 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
12997000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34830000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
102299000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
99047000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54295000
CY2018Q3 us-gaap Assets
Assets
6529584000
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
33264000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
133914000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
109151000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
114414000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
141213000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
390743000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
377389000
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3181962000
CY2018Q3 us-gaap Liabilities
Liabilities
3820637000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3205058000
CY2018Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
82269000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
80333000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
165663000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
166434000
CY2017Q4 us-gaap Liabilities
Liabilities
3829214000
CY2018Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
28698000
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
22417000
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
874000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
871000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2535377000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2517545000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-440462000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-374118000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
584460000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
428573000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
2680249000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2572871000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6529584000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6424502000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
180000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87363357
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87060114
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87363357
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87060114
achc Health Care Organization Revenues
HealthCareOrganizationRevenues
2268895000
achc Health Care Organization Revenues
HealthCareOrganizationRevenues
2143696000
CY2017Q3 achc Health Care Organization Patient Service Provision For Bad Debts
HealthCareOrganizationPatientServiceProvisionForBadDebts
11998000
achc Health Care Organization Patient Service Provision For Bad Debts
HealthCareOrganizationPatientServiceProvisionForBadDebts
31892000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2268895000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2111804000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1246186000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1145578000
us-gaap Professional Fees
ProfessionalFees
166988000
us-gaap Professional Fees
ProfessionalFees
142772000
us-gaap Operating Expenses
OperatingExpenses
1935645000
us-gaap Supplies Expense
SuppliesExpense
88958000
us-gaap Supplies Expense
SuppliesExpense
85000000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
60390000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
57455000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
265977000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
119360000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
105256000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-137706000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
18836000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
176159000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46259000
us-gaap Profit Loss
ProfitLoss
129900000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-306000
us-gaap Net Income Loss
NetIncomeLoss
130206000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.50
us-gaap Share Based Compensation
ShareBasedCompensation
19007000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
188744000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-24354000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
294290000
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
3278000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10672000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28681000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-26099000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
566000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26381000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7937000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7677000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
272612000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1261000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
271351000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
193817000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
33297000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-306000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
294596000
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
-18800000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
244000
achc Common Stock Withheld For Minimum Statutory Taxes
CommonStockWithheldForMinimumStatutoryTaxes
2516000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19273000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
834000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7340000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
29416000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
6062000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-233176000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
25913000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1649000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27542000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7965000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
18598000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75661000
achc Number Of Facilities
NumberOfFacilities
586
CY2018Q3 achc Number Of Beds
NumberOfBeds
18000
CY2018Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
40
CY2018Q3 achc Net Cost Report Settlement Due From Due To
NetCostReportSettlementDueFromDueTo
10900000
CY2017Q4 achc Net Cost Report Settlement Due From Due To
NetCostReportSettlementDueFromDueTo
10900000
us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
3800000
us-gaap Charity Care Direct And Indirect Cost Basis Amount
CharityCareDirectAndIndirectCostBasisAmount
4200000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
153000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1500000
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3247000
CY2018Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
91259000
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
87348000
CY2018Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94506000
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
90595000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3247000
CY2018Q3 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
87367
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.67
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
37.36
CY2017Q4 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
0
CY2018Q3 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2017Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
3247000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3571765000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3395549000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
445123000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
347419000
CY2018Q3 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
43602000
CY2017Q4 achc Debt Instrument Unamortized Issuance Costs Discount Premium Net
DebtInstrumentUnamortizedIssuanceCostsDiscountPremiumNet
50432000
CY2018Q3 us-gaap Long Term Debt
LongTermDebt
3215226000
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
3239888000
CY2017Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
22500000
CY2018Q2 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
15000000
CY2014Q4 achc Consolidated Funded Debt Maximum
ConsolidatedFundedDebtMaximum
40000000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8200000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3233738
achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
47800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y2M12D
CY2018Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1000946
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
259300
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
198313
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
974566
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
353800
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9889
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
102787
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1215690
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
405634
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
543139
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.42
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
42.25
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
25.92
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
54.71
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
51.23
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.69
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
41.20
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
44.65
achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y5M1D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M4D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M13D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8166000
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
205000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1636000
CY2017 achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3802000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
475000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
165000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
0
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3536000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3549000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2835000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.61
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.095
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.37
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1200000
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvision
1700000
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.007
achc New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption On Income Tax Provision As Percentage
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionOnIncomeTaxProvisionAsPercentage
0.010
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
achc Transition Tax On Certain Repatriated Earnings Of Foreign Subsidiaries Payable Period
TransitionTaxOnCertainRepatriatedEarningsOfForeignSubsidiariesPayablePeriod
P8Y
achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit
19300000
CY2018Q3 achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting One Time Transition Tax Liability For Foreign Subsidiaries
TaxCutsAndJobsActOf2017IncompleteAccountingOneTimeTransitionTaxLiabilityForForeignSubsidiaries
0
CY2018Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
19300000
achc Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
0
achc Income Tax Reconciliation Foreign Dividends And Earnings Taxable
IncomeTaxReconciliationForeignDividendsAndEarningsTaxable
10900000
CY2018Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
33100000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
75000000
achc Number Of Facilities Operated By Non Wholly Owned Subsidiaries
NumberOfFacilitiesOperatedByNonWhollyOwnedSubsidiaries
4
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
6125000
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-156000
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35682000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27320000
CY2018Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30203000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
30455000
CY2018Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11326000
CY2018Q3 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2017Q4 achc Workers Compensation Deposits
WorkersCompensationDeposits
10000000
CY2018Q3 us-gaap Inventory Net
InventoryNet
5021000
CY2017Q4 us-gaap Inventory Net
InventoryNet
4787000
CY2018Q3 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
2049000
CY2017Q4 us-gaap Insurance Receivable For Malpractice Current
InsuranceReceivableForMalpracticeCurrent
17588000
CY2018Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1865000
CY2017Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2129000
CY2018Q3 achc Accrued Expense Current
AccruedExpenseCurrent
42876000
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31581000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31342000
CY2018Q3 us-gaap Interest Payable Current
InterestPayableCurrent
12835000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
36370000
CY2018Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11312000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1012000
CY2018Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
4956000
CY2017Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
22788000
CY2018Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
5570000
CY2017Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3945000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5284000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8488000
CY2017Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
716714000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
2268895000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
2111804000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
152256000
us-gaap Operating Income Loss
OperatingIncomeLoss
459669000
us-gaap Operating Income Loss
OperatingIncomeLoss
450845000
achc Goodwill Increase From Contribution Of Redeemable Noncontrolling Interests
GoodwillIncreaseFromContributionOfRedeemableNoncontrollingInterests
2244000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-24239000
us-gaap Indefinite Lived Intangible Assets Purchase Accounting Adjustments
IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
762000

Files In Submission

Name View Source Status
0001564590-18-027458-index-headers.html Edgar Link pending
0001564590-18-027458-index.html Edgar Link pending
0001564590-18-027458.txt Edgar Link pending
0001564590-18-027458-xbrl.zip Edgar Link pending
achc-10q_20180930.htm Edgar Link pending
achc-20180930.xml Edgar Link completed
achc-20180930.xsd Edgar Link pending
achc-20180930_cal.xml Edgar Link unprocessable
achc-20180930_def.xml Edgar Link unprocessable
achc-20180930_lab.xml Edgar Link unprocessable
achc-20180930_pre.xml Edgar Link unprocessable
achc-ex311_8.htm Edgar Link pending
achc-ex312_7.htm Edgar Link pending
achc-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending